PlainRecalls
FDA Drug Low Class III Terminated

Telmisartan and Amlodipine Tablets 80 mg/5 mg, 30 tablet bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD, Manufactured by : Lupin Limited, Goa, INDIA -- NDC 68180-198-06

Reported: April 17, 2019 Initiated: April 1, 2019 #D-1121-2019

Product Description

Telmisartan and Amlodipine Tablets 80 mg/5 mg, 30 tablet bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD, Manufactured by : Lupin Limited, Goa, INDIA -- NDC 68180-198-06

Reason for Recall

Failed Impurities/Degradation Specifications; 18 month long term stability study.

Details

Units Affected
12,504 bottles
Distribution
Product was distributed to 6 wholesalers/ drug chains and 2 mail order pharmacies that may have further distribute the product throughout the United States.
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Telmisartan and Amlodipine Tablets 80 mg/5 mg, 30 tablet bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD, Manufactured by : Lupin Limited, Goa, INDIA -- NDC 68180-198-06. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 12,504 bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications; 18 month long term stability study.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 17, 2019. Severity: Low. Recall number: D-1121-2019.